Summary statement: Utility of molecular marker testing in thyroid cancer
- 31 December 2010
- Vol. 148 (6) , 1313-1315
- https://doi.org/10.1016/j.surg.2010.09.023
Abstract
No abstract availableKeywords
This publication has 23 references indexed in Scilit:
- Circulating Thyrotropin Receptor mRNA as a Novel Marker of Thyroid CancerAnnals of Surgery, 2010
- B-RafV600Eand thrombospondin-1 promote thyroid cancer progressionProceedings of the National Academy of Sciences, 2010
- Revised American Thyroid Association Management Guidelines for Patients with Thyroid Nodules and Differentiated Thyroid CancerThyroid®, 2009
- BRAF Mutation Testing of Thyroid Fine-Needle Aspiration Biopsy Specimens for Preoperative Risk Stratification in Papillary Thyroid CancerJournal of Clinical Oncology, 2009
- Molecular Testing for Mutations in Improving the Fine-Needle Aspiration Diagnosis of Thyroid NodulesJournal of Clinical Endocrinology & Metabolism, 2009
- Effectiveness of Peripheral Thyrotropin Receptor mRNA in Follow-Up of Differentiated Thyroid CancerAnnals of Surgical Oncology, 2008
- Differentiating Alternative Splice Variant Patterns of Human Telomerase Reverse Transcriptase in Thyroid NeoplasmsThyroid®, 2008
- Discovery of a selective inhibitor of oncogenic B-Raf kinase with potent antimelanoma activityProceedings of the National Academy of Sciences, 2008
- The Prevalence and Prognostic Value of BRAF Mutation in Thyroid CancerAnnals of Surgery, 2007
- Diagnostic and prognostic value of angiogenesis-modulating genes in malignant thyroid neoplasmsSurgery, 2005